Prasugrel-based De-Escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With STEMI.

Korean Circ J · 2022 · PMC8989793 · PMID 35129316

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Further, primary analysis and landmark analysis showed no benefits of de-escalation in terms of bleeding and a slight trend toward worse ischemic outcomes for the de-escalation group in STEMI patients.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.